These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26984971)

  • 1. A Universal Culture Medium for Screening Polymyxin-Resistant Gram-Negative Isolates.
    Nordmann P; Jayol A; Poirel L
    J Clin Microbiol; 2016 May; 54(5):1395-9. PubMed ID: 26984971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of colistin-resistant Gram-negative rods by using the SuperPolymyxin medium.
    Jayol A; Poirel L; André C; Dubois V; Nordmann P
    Diagn Microbiol Infect Dis; 2018 Oct; 92(2):95-101. PubMed ID: 29885757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHROMagar COL-APSE: a selective bacterial culture medium for the isolation and differentiation of colistin-resistant Gram-negative pathogens.
    Abdul Momin MHF; Bean DC; Hendriksen RS; Haenni M; Phee LM; Wareham DW
    J Med Microbiol; 2017 Nov; 66(11):1554-1561. PubMed ID: 28984232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance cultures for detection of rectal and lower respiratory tract carriage of colistin-resistant Gram-negative bacilli in intensive care unit patients: comparison of direct plating and pre-enrichment step.
    Germ J; Cerar Kišek T; Kokošar Ulčar B; Lejko Zupanc T; Mrvič T; Kerin Povšič M; Seme K; Pirs M
    J Med Microbiol; 2019 Sep; 68(9):1269-1278. PubMed ID: 31237536
    [No Abstract]   [Full Text] [Related]  

  • 5. LBJMR medium: a new polyvalent culture medium for isolating and selecting vancomycin and colistin-resistant bacteria.
    Bardet L; Le Page S; Leangapichart T; Rolain JM
    BMC Microbiol; 2017 Nov; 17(1):220. PubMed ID: 29169321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The added value of the selective SuperPolymyxin™ medium in detecting rectal carriage of Gram-negative bacteria with acquired colistin resistance in intensive care unit patients receiving selective digestive decontamination.
    van Hout D; Janssen AB; Rentenaar RJ; Vlooswijk JPM; Boel CHE; Bonten MJM
    Eur J Clin Microbiol Infect Dis; 2020 Feb; 39(2):265-271. PubMed ID: 31691864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of polymyxin resistance: knowns and unknowns.
    Baron S; Hadjadj L; Rolain JM; Olaitan AO
    Int J Antimicrob Agents; 2016 Dec; 48(6):583-591. PubMed ID: 27524102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary Gram-negative pathogens in New York City.
    Quale J; Shah N; Kelly P; Babu E; Backer M; Rosas-Garcia G; Salamera J; George A; Bratu S; Landman D
    Microb Drug Resist; 2012 Apr; 18(2):132-6. PubMed ID: 22196342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of polymyxin resistance in Gram-negative bacteria.
    Olaitan AO; Li J
    Int J Antimicrob Agents; 2016 Dec; 48(6):581-582. PubMed ID: 27939183
    [No Abstract]   [Full Text] [Related]  

  • 10. A selective culture medium for screening linezolid-resistant gram-positive bacteria.
    Nordmann P; Rodríguez-Villodres A; Poirel L
    Diagn Microbiol Infect Dis; 2019 Sep; 95(1):1-4. PubMed ID: 30981556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activity of the novel polymyxin derivative NAB739 tested against Gram-negative pathogens.
    Vaara M; Sader HS; Rhomberg PR; Jones RN; Vaara T
    J Antimicrob Chemother; 2013 Mar; 68(3):636-9. PubMed ID: 23134658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of infections caused by polymyxin-resistant pathogens.
    Giamarellou H
    Int J Antimicrob Agents; 2016 Dec; 48(6):614-621. PubMed ID: 27865627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of Polymyxin by Hydrolytic Mechanism.
    Yin J; Wang G; Cheng D; Fu J; Qiu J; Yu Z
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations.
    Ezadi F; Ardebili A; Mirnejad R
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30541939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of polymyxin resistance and detection of mcr genes.
    Mlynarcik P; Kolar M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Feb; 163(1):28-38. PubMed ID: 30439931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of susceptibility testing methods for polymyxin.
    Behera B; Mathur P; Das A; Kapil A; Gupta B; Bhoi S; Farooque K; Sharma V; Misra MC
    Int J Infect Dis; 2010 Jul; 14(7):e596-601. PubMed ID: 20045367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections.
    Brown P; Dawson MJ
    J Antibiot (Tokyo); 2017 Apr; 70(4):386-394. PubMed ID: 28074057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?
    Blaskovich MAT; Pitt ME; Elliott AG; Cooper MA
    Expert Rev Anti Infect Ther; 2018 Jun; 16(6):485-499. PubMed ID: 29848132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to polymyxins: Mechanisms, frequency and treatment options.
    Falagas ME; Rafailidis PI; Matthaiou DK
    Drug Resist Updat; 2010; 13(4-5):132-8. PubMed ID: 20843473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymyxin B consumption and incidence of gram-negative bacteria intrinsically resistant to polymyxins.
    Falci DR; Pacheco LS; Puga LS; da Silva RC; Alves AP; Behar PR; Zavascki AP
    Infect Control Hosp Epidemiol; 2012 May; 33(5):536-7. PubMed ID: 22476287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.